Drug firm, Elder Pharmaceuticals is planning to increase its market share by foraying into the growing personal and lifestyle healthcare sector including hypertension, diabetes and cardiac care. The pharma major’s main strength is marketing the women's healthcare product - Shelcal which is a calcium supplement used to prevent osteoporosis, and its extensions.
The company has recently added manufacturing plant in New Bombay, pursuant to which it has acquired a strong presence in women's healthcare, nutraceuticals, anti-infectives, lifestyle diseases and pain management.
Elder Pharmaceuticals (EPL) is engaged in the manufacturing and marketing of mainly pharmaceutical formulations, under its own as well as in-licensed brands, and offers a gamut of products in the Active Pharmaceutical Ingredients (API)/bulk drugs. The company is also a distributor of the cosmeceutical products.
